APS-001F

N/A

Report date: 2026/03/11 20:02:12

Base Information

Drug NameAPS-001F

Drug Alias NameAPS001FBEST-CDBifidobactErial Selective Targeting-Cytosine Deaminase therapyAPS-001FAPS-001

ClassificationCell and gene therapy > Gene therapyBiologics > Live BiotherapeuticCell and gene therapy > Gene therapy > Bacterial vector-based gene therapy > Bifidobacterium longum vector

Mechanisms of ActionCytosine deaminase stimulants

TargetsCytosine deaminase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAnaeropharma Science Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAnaeropharma Science Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A